From protein interaction networks to novel therapeutic strategies.

Joint IRB-BSC program in Computational Biology, Institute for Research in Biomedicine, Barcelona, Spain.
International Union of Biochemistry and Molecular Biology Life (Impact Factor: 2.79). 05/2012; 64(6):529-37. DOI: 10.1002/iub.1040
Source: PubMed

ABSTRACT Cellular mechanisms that sustain health or contribute to disease emerge mostly from the complex interplay among various molecular entities. To understand the underlying relationships between genotype, environment and phenotype, one has to consider the intricate and nonsequential interaction patterns formed between the different sets of cellular players. Biological networks capture a variety of molecular interactions and thus provide an excellent opportunity to consider physiological characteristics of individual molecules within their cellular context. In particular, the concept of network biology and its applications contributed largely to recent advances in biomedical research. In this review, we show (i) how biological networks, i.e., protein-protein interaction networks, facilitate the understanding of pathogenic mechanisms that trigger the onset and progression of diseases and (ii) how this knowledge can be translated into effective diagnostic and therapeutic strategies. In particular, we focus on the impact of network pharmacological concepts that go beyond the classical view on individual drugs and targets aiming for combinational therapies with improved clinical efficacy and reduced safety risks.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The past decade has seen a dramatic expansion in the number and range of techniques available to obtain genome-wide information and to analyze this information so as to infer both the functions of individual molecules and how they interact to modulate the behavior of biological systems. Here, we review these techniques, focusing on the construction of physical protein-protein interaction networks, and highlighting approaches that incorporate protein structure, which is becoming an increasingly important component of systems-level computational techniques. We also discuss how network analyses are being applied to enhance our basic understanding of biological systems and their disregulation, as well as how these networks are being used in drug development.
    Annual review of biophysics. 05/2014; 43:193-210.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Protein-protein interactions drive biological processes. They are critical for all intra and extra cellular functions, and the technologies to analyse them are widely applied throughout the various fields of biological sciences. This article takes an in depth view of some common principles of cellular regulation and provides a detailed account of approaches required to comprehensively map signalling protein-protein interactions in any particular cellular system or condition. We provide a critical review of benefits and disadvantages of the yeast-two-hybrid method and affinity purification coupled with mass spectrometric (AP-MS) procedures for identification of signalling protein-protein interactions. In particular we emphasize the quantitative and qualitative differences between tandem affinity (TAP) and one-step purification (such as Flag- and Strep-tag) methods. Albeit applicable to all type of interaction studies, a special section is devoted in this review to aspects that should be considered when attempting to identify signalling protein interactions that often are transient and weak by nature. Finally, we discuss shotgun and quantitative information that can be gleaned by MS-coupled methods for analysis of multiprotein complexes.
    Molecular &amp Cellular Proteomics 03/2013; · 7.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Novel classes of antimicrobials are needed to address the challenge of multidrug-resistant bacteria. Current bacterial drug targets mainly consist of specific proteins or subsets of proteins without regard for either how these targets are integrated in cellular networks or how they may interact with host proteins. However, proteins rarely act in isolation, and the majority of biological processes are dependent on interactions with other proteins. Consequently, protein-protein interaction (PPI) networks offer a realm of unexplored potential for next-generation drug targets. In this review, we argue that the architecture of bacterial or host-pathogen protein interactomes can provide invaluable insights for the identification of novel antibacterial drug targets.
    Current opinion in microbiology 08/2013; · 7.87 Impact Factor